Aarhus Medical ApS: Financial statements 2022
CVR: 40981551
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Aarhus Medical ApS (CVR 40981551) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -71,825 and a net result of DKK -90,248 compared with DKK -115,298 the year before. Equity in the 2022 report amounted to DKK -139,834. The company had 1 employee in the financial year.
- Gross Profit
- DKK -71,825
- Profit/Loss
- DKK -90,248
- Equity
- DKK -139,834
- Total Assets
- DKK 2,478,011
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -72K | -90K | -140K | 1 |
| 2021 | - | -60K | -115K | -50K | 1 |
| 2020 | - | -13K | -14K | 66K | 0 |
Official annual report
Keep an eye on Aarhus Medical ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Aarhus Medical ApS has published its annual report for 2021. Gross profit came to DKK -59,987, and the net result was DKK -115,298.
As of March 1, 2022, Morten Haaning Charles is registered as director of Aarhus Medical ApS.
As of February 28, 2022, Morten Haaning Charles has left the board of directors of Aarhus Medical ApS.
As of February 28, 2022, Hanne Everland has stepped down as director of Aarhus Medical ApS.
About Aarhus Medical ApS
Aarhus Medical ApS is a Danish company of the type Anpartsselskab based in Risskov, founded in 2019. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Morten Haaning Charles. The board consists of Anders Geert (chair) and Jesper Fleischer. The company's owners include Peter Christian Boldsen, ANDERS GEERT HOLDING ApS and C.B. Fleischer ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,310,771 and a net result of DKK 913,936 compared with DKK -193,642 the year before. Equity in the 2025 report amounted to DKK 317,240.
